Related Experiment Video
Updated: Jun 6, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
HPV self-sampling for cervical cancer screening in China: A multi-center study
Xuechao Ji1, Menglin Hao1, Yixiao Wang1
1Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Beijing Maternal and Child Health Care Hospital, China.
Human papillomavirus (HPV) self-sampling is accurate and accepted by women in China. This method can supplement traditional cervical cancer screening, especially with clinician support.
Area of Science:
- Gynecology
- Public Health
- Virology
Background:
- Research on human papillomavirus (HPV) self-sampling in diverse Chinese populations is limited.
- HPV self-sampling offers a novel approach for collecting cervical cells.
Purpose of the Study:
- To assess the accuracy and acceptability of HPV self-sampling in China.
- To analyze HPV infection patterns across different demographics.
Main Methods:
- Recruited 5417 women aged 25-65 from 8 Chinese provinces.
- Collected paired clinician and self-samples for HPV genotyping (23 types) via PCR.
- Administered a questionnaire on HPV self-sampling acceptance.
Main Results:
- Crude agreement between self- and clinician-sampling was 93.06%.
- 43.79% of women preferred self-sampling; 67.59% preferred performing it at the hospital.
- HPV 52, 58, 16, 39, and 68 were the most prevalent genotypes, with the highest infection rate in the 25-30 age group.
Conclusions:
- HPV self-sampling is a viable supplement to traditional cervical screening in China.
- Clinician support and clear guidance are crucial for effective implementation.
- Screening and vaccination strategies may need adaptation for diverse populations.
More Related Videos
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014